Get the Stockscreener App
0.65
6.00%
-0.0415
After Hours:
.65
Novabay Pharmaceuticals Inc Stock (NBY) Forecast
The Novabay Pharmaceuticals Inc (NBY) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $7.8248, representing a +1,104% increase from the current price of $0.65. The highest analyst price target is $10.31, and the lowest is $5.3373.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NBY Price Target
Average 28.99
(+4,360% Upside)
Is Novabay Pharmaceuticals Inc (NBY) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 47.98 | Neutral |
| STOCH(9,6) | 33.09 | Neutral |
| STOCHRSI(14) | 10.26 | Buy |
| MACD(12,26) | 0.0205 | Sell |
| ADX(14) | 14.86 | Neutral |
| William %R | -55.22 | Neutral |
| CCI(14) | -54.69 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.7078
Sell
|
0.6899
Sell
|
| MA20 |
0.6853
Sell
|
0.6767
Sell
|
| MA50 |
0.6305
Buy
|
0.6609
Sell
|
| MA100 |
0.6337
Buy
|
0.868
Sell
|
| MA200 |
1.4212
Sell
|
2.2007
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, NBY could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 9 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on NBY, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 47.98 indicates that NBY is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 33.09 indicates that NBY is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 10.26 indicates that NBY is oversold. This suggests that NBY price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 14.86 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -54.69 indicates that NBY is still oversold but not to an extreme extent.
Long-term NBY price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Novabay Pharmaceuticals Inc financial reports and earnings history, Novabay Pharmaceuticals Inc (NBY) stock could reach $108.05 by 2030, $9.7277 by 2040 and $27.20 by 2050. See the projected annual prices until 2050 of the Novabay Pharmaceuticals Inc stock below:
- Novabay Pharmaceuticals Inc (NBY) is expected to reach an average price of $3.0735 in 2035, with a high prediction of $3.4939 and a low estimate of $3.0899. This indicates an $372.84% rise from the last recorded price of $0.65.
- Novabay Pharmaceuticals Inc (NBY) stock is projected to chart a bullish course in 2040, with an average price target of $9.7912, representing an $1,406% surge from its current level. The forecast ranges from a conservative $9.6033 to a sky-high $9.7277.
- Our analysts predict Novabay Pharmaceuticals Inc (NBY) to jump 2,770% by 2045, soaring from $18.48 to an average price of $18.66, potentially reaching $18.02. While $18.48 is the low estimate, the potential upside is significant.
- Novabay Pharmaceuticals Inc (NBY) stock is expected to climb by 2050, reaching an average of $26.49, a $3,975% jump from its current level. However, a wide range of estimates exists, with high and low targets of $27.20 and $27.70, respectively, highlighting the market's uncertainty.
Novabay Pharmaceuticals Inc Stock (NBY) Year by Year Forecast
Novabay Pharmaceuticals Inc Stock (NBY) Price Forecast for 2025
Novabay Pharmaceuticals Inc Stock (NBY) is expected to reach an average price of $28.99 in 2025, with a high prediction of $54.90 and a low estimate of $3.0819. This indicates an +4,360% rise from the last recorded price of $0.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2025 | $6.2921 | $5.3373 | $10.31 | +868.01% |
| March, 2025 | $5.4611 | $3.0819 | $8.7791 | +740.18% |
| April, 2025 | $6.8086 | $3.5865 | $40.77 | +947.47% |
| May, 2025 | $31.09 | $4.8605 | $50.95 | +4,683% |
| June, 2025 | $17.57 | $16.18 | $28.37 | +2,603% |
| July, 2025 | $19.61 | $14.95 | $23.11 | +2,917% |
| August, 2025 | $26.84 | $18.97 | $33.38 | +4,029% |
| September, 2025 | $26.90 | $24.91 | $54.90 | +4,039% |
| October, 2025 | $14.77 | $10.91 | $37.34 | +2,172% |
| November, 2025 | $13.24 | $11.78 | $17.97 | +1,937% |
| December, 2025 | $9.2406 | $8.9746 | $18.20 | +1,322% |
Novabay Pharmaceuticals Inc Stock (NBY) Price Forecast for 2026
The predicted value for Novabay Pharmaceuticals Inc (NBY) in 2026 is set at an average of $28.83. Estimates vary from a peak of $51.60 to a trough of $6.057, indicating an +4,335% surge from the present price of $0.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $10.43 | $6.057 | $12.09 | +1,504% |
| February, 2026 | $11.15 | $9.3539 | $15.88 | +1,615% |
| March, 2026 | $20.63 | $10.20 | $28.56 | +3,073% |
| April, 2026 | $33.40 | $18.88 | $51.60 | +5,038% |
| May, 2026 | $28.03 | $16.54 | $45.71 | +4,212% |
| June, 2026 | $19.99 | $18.69 | $29.14 | +2,975% |
| July, 2026 | $12.86 | $11.18 | $20.26 | +1,879% |
| August, 2026 | $15.52 | $12.21 | $17.92 | +2,287% |
| September, 2026 | $12.49 | $11.39 | $20.69 | +1,821% |
| October, 2026 | $12.05 | $10.10 | $17.25 | +1,754% |
| November, 2026 | $14.23 | $10.51 | $14.48 | +2,090% |
| December, 2026 | $13.45 | $11.73 | $17.91 | +1,969% |
Novabay Pharmaceuticals Inc Stock (NBY) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Novabay Pharmaceuticals Inc (NBY) is $6.7703, with a high forecast of $13.49 and a low forecast of $0.0476. This indicates an +941.59% increase from the last price of $0.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $9.8257 | $9.3448 | $13.49 | +1,412% |
| February, 2027 | $8.2177 | $7.1677 | $13.35 | +1,164% |
| March, 2027 | $8.0637 | $5.6473 | $12.35 | +1,141% |
| April, 2027 | $3.9672 | $3.6242 | $8.0721 | +510.34% |
| May, 2027 | $3.7225 | $1.8665 | $5.1208 | +472.69% |
| June, 2027 | $2.6042 | $1.8419 | $4.8176 | +300.64% |
| July, 2027 | $3.0507 | $1.683 | $4.8693 | +369.34% |
| August, 2027 | $1.8558 | $0.6098 | $3.925 | +185.50% |
| September, 2027 | $0.0658 | $0.3822 | $2.0637 | -89.88% |
| October, 2027 | $0.4263 | $0.0476 | $5.5615 | -34.42% |
| November, 2027 | $4.2608 | $0.2036 | $5.4193 | +555.51% |
| December, 2027 | $3.7427 | $1.178 | $6.5777 | +475.80% |
Novabay Pharmaceuticals Inc Stock (NBY) Price Forecast for 2028
In 2028, Novabay Pharmaceuticals Inc (NBY) is projected to reach an average price of $1.959, with a high projection of $3.8001 and a low estimate of $0.1178. This indicates an +201.38% rise from the last price of $0.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.2748 | $1.8183 | $3.8001 | +249.96% |
| February, 2028 | $1.7482 | $0.1178 | $2.3217 | +168.95% |
| March, 2028 | $1.6013 | $1.7203 | $1.7209 | +146.35% |
| April, 2028 | $2.8017 | $1.9534 | $2.5317 | +331.03% |
| May, 2028 | $3.3748 | $2.9269 | $3.1248 | +419.20% |
| June, 2028 | $2.4103 | $2.5302 | $2.7274 | +270.82% |
| July, 2028 | $2.1557 | $2.0527 | $2.1008 | +231.65% |
| August, 2028 | $2.4188 | $1.9461 | $1.9209 | +272.12% |
| September, 2028 | $2.2192 | $2.2192 | $2.334 | +241.42% |
| October, 2028 | $2.6197 | $2.1944 | $2.4197 | +303.03% |
| November, 2028 | $2.7026 | $2.6822 | $2.7001 | +315.79% |
| December, 2028 | $2.321 | $2.41 | $2.5154 | +257.08% |
Novabay Pharmaceuticals Inc Stock (NBY) Price Forecast for 2029
The 2029 price forecast for Novabay Pharmaceuticals Inc Stock (NBY) is $1.2731 on average, with a high prediction of $2.4788 and a low estimate of $0.0674. This represents an +95.86% increase from the previous price of $0.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.086 | $2.0863 | $2.2558 | +220.92% |
| February, 2029 | $1.9537 | $1.9667 | $1.9989 | +200.57% |
| March, 2029 | $1.8172 | $1.8096 | $1.8643 | +179.57% |
| April, 2029 | $1.7175 | $1.735 | $1.7698 | +164.24% |
| May, 2029 | $1.4905 | $1.4927 | $1.6353 | +129.31% |
| June, 2029 | $1.2747 | $1.2912 | $1.4083 | +96.10% |
| July, 2029 | $1.1476 | $1.1506 | $1.2173 | +76.56% |
| August, 2029 | $0.8931 | $0.9135 | $1.0762 | +37.40% |
| September, 2029 | $0.6811 | $0.6901 | $0.8277 | +4.79% |
| October, 2029 | $0.412 | $0.4141 | $0.6181 | -36.61% |
| November, 2029 | $0.2363 | $0.2476 | $0.3408 | -63.65% |
| December, 2029 | $16.87 | $0.0674 | $2.4788 | +2,496% |
Novabay Pharmaceuticals Inc Stock (NBY) Price Forecast for 2030
Novabay Pharmaceuticals Inc Stock (NBY) is expected to reach an average price of $54.43 in 2030, with a high forecast of $108.05 and a low forecast of $0.8144. This signifies an +8,274% surge from the last price of $0.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $27.65 | $22.48 | $108.05 | +4,153% |
| February, 2030 | $16.64 | $14.36 | $45.17 | +2,459% |
| March, 2030 | $10.10 | $2.3413 | $23.46 | +1,453% |
| April, 2030 | $12.71 | $0.8144 | $14.94 | +1,855% |
| May, 2030 | $9.3637 | $10.22 | $11.48 | +1,341% |
| June, 2030 | $11.69 | $10.05 | $9.5955 | +1,699% |
| July, 2030 | $10.87 | $10.76 | $10.17 | +1,573% |
| August, 2030 | $9.1492 | $9.8338 | $9.019 | +1,308% |
| September, 2030 | $7.6121 | $7.8599 | $6.8092 | +1,071% |
| October, 2030 | $10.93 | $8.2156 | $9.7963 | +1,582% |
| November, 2030 | $16.51 | $9.2167 | $11.26 | +2,440% |
| December, 2030 | $0.4004 | $2.9371 | $26.62 | -38.40% |
5.49%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):